As covered in our Funding in 2022 piece, last year was a more difficult fundraising environment for companies in the psychedelics space and beyond. But, a number of companies were still able to pique investor interest and raise significant rounds. Psychedelic Alpha spoke with three psychedelic company CEOs who raised in 2022 to learn more about their fundraising process and advice for fellow…


Previous articlePT383 – Identity, Rage, Culture, and Venture Capital
Next articleDiamond Therapeutics Announces Health Canada Approval of Phase 2 Clinical Trial with Low-Dose Psilocybin